Tissue-specific
insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest
105:199-205
Shepherd PR, Withers DJ, Siddle K (1998). Phosphoinositide 3-kinase: the key switch
al., J. Pharmacol. Exp. Ther., 275, 368-373 (1995).
51. Yokotani, K., et al., Eur. J. Pharmacol., 459, 187-193 (2003).
52. Kiriyama, M., et al., Br. J. Pharmacol., 122, 217-224 (1997).
53. Bygdeman, M.
) M6565 M y y n/d
459 MRP1 M9192 M y n/d n/d
460 MRP2 M3692 M y n/d n/d
461 α-MSH M0939 P y n/d n/d
462 MSH6 M2445 P y y y
463 MSH6 M2820 P y y n/d
464 MSK-1 M5437 P y
phospho-Abltide WB APur Rb IgG 200 µg 07-516
Proteins and Peptides
Abl, active, mouse KA 10 µg 14-459
Abl (T315I), active KA 10 µg 14-522
Abl, active KA 10 µg 14-529
Abltide KA 1 mg
NP_113968.1,NP_005494.2,NP_031487.1 P n/d n/d y
458 MRP1 M6565 4363 ABCC1 NP_063955.2 M y n/d n/d
459 MRP1 M9192 4363 ABCC1 NP_063955.2 M y n/d n/d
460 MRP2 M3692 1244 ABCC2 NP_000383.1 M y n/d n/d
461
031487.1 P n/d n/d y
458 LRRK2 (PARK8) M6565 66725, 120892 Lrrk2, LRRK2 NM_025730, NM_198578 M y y n/d
459 MRP1 M9192 4363 ABCC1 NP_063955.2 M y n/d n/d
460 MRP2 M3692 1244 ABCC2 NP_000383.1 M y n/d n/d
461